Literature DB >> 16784850

Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.

Aloysius T Nchinda1, Kelly Chibale, Pierre Redelinghuys, Edward D Sturrock.   

Abstract

Novel analogues of the angiotensin I-converting enzyme (ACE) inhibitor keto-ACE were synthesized via a facile Horner-Emmons olefination of a phosphonoketone precursor with ethyl glyoxylate. Introduction of a bulky aromatic tryptophan at the P(2)(') position of keto-ACE resulted in a significant increase in C-domain-selectivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784850     DOI: 10.1016/j.bmcl.2006.06.003

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Interkingdom pharmacology of Angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes.

Authors:  Glenna J Kramer; Akif Mohd; Sylva L U Schwager; Geoffrey Masuyer; K Ravi Acharya; Edward D Sturrock; Brian O Bachmann
Journal:  ACS Med Chem Lett       Date:  2014-02-04       Impact factor: 4.345

2.  Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors.

Authors:  Ross G Douglas; Rajni K Sharma; Geoffrey Masuyer; Lizelle Lubbe; Ismael Zamora; K Ravi Acharya; Kelly Chibale; Edward D Sturrock
Journal:  Clin Sci (Lond)       Date:  2014-02       Impact factor: 6.124

Review 3.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

4.  Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension.

Authors:  Rhéure Alves-Lopes; Augusto C Montezano; Karla B Neves; Adam Harvey; Francisco J Rios; Dominik S Skiba; Lauren B Arendse; Tomasz J Guzik; Delyth Graham; Marko Poglitsch; Edward Sturrock; Rhian M Touyz
Journal:  Hypertension       Date:  2021-07-26       Impact factor: 10.190

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.